Aptus Pharmaceuticals

Gaithersburg, United States Founded: 2010 • Age: 16 yrs
Limited information available

About Aptus Pharmaceuticals

Aptus Pharmaceuticals is a company based in Gaithersburg (United States) founded in 2010. Limited information available. Aptus Pharmaceuticals has raised $6.2 million across 1 funding round from investors including Vital Bio Systems, Emerging Technology Partners and ROMA99. The company has 28 employees. Its Indian entity Aptus Pharma Limited reported revenue of β‚Ή46.70 Cr. Aptus Pharmaceuticals offers products and services including Pharmaceutical Products and Export Services.

Company details

Aptus Pharmaceuticals was founded in 2010 and is located in Gaithersburg, United States. Operations are centered in the pharmaceutical sector, where drug discovery and formulation activities are undertaken. Research efforts are directed toward therapeutic solutions, with manufacturing processes handled domestically. The company maintains a presence through its domain aptuspharma.com, serving the healthcare industry in the region.

  • Headquarters Gaithersburg, United States
  • Employees 28
  • Website aptuspharma.com
  • Legal Name Aptus Pharma Ltd.
  • Date of Incorporation 12 Aug, 2010
  • Jurisdiction Ahmedabad, Gujarat, India
Key Metrics
  • Indian entity revenue
    ₹46.70 Cr

    FY 2026 · +90% YoY

  • Indian entity net profit
    ₹4.60 Cr

    FY 2026 · 10% margin

  • Indian entity EBITDA
    ₹7.43 Cr

    FY 2026 · 16% margin

  • Total Equity Funding
    $6.2M (USD)

    in 1 rounds

  • Latest Funding Round
    $6.2M (USD), Series A

    May 2011

  • Investors
  • Employee Count
    28

Products & Services of Aptus Pharmaceuticals

Aptus Pharmaceuticals offers a comprehensive portfolio of products and services, including Pharmaceutical Products and Export Services.

Pharmaceutical Products
Healthcare Products

Pharmaceutical drugs are manufactured and sold for healthcare purposes, with compliance to international standards being maintained.

Export Services
Distribution Services

International export of pharmaceutical products is handled through a dedicated division, as expansion plans are outlined in the company's profile.

Funding Insights of Aptus Pharmaceuticals

Aptus Pharmaceuticals has successfully raised a total of $6.2M through 1 strategic funding round. The most recent funding activity was a Series A round of $6.2 million completed in May 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $6.2M
  • Total Rounds 1
  • Last Round Series A β€” $6.2M
  • First Round $6.2M

    (May 2011)

  • Investors Count 3

All 1 funding rounds of Aptus Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2011$6.2MSeries A––
Valuation history

3 investors in total: 3 institutional.

Investors in Aptus Pharmaceuticals

Aptus Pharmaceuticals has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Vital Bio Systems, Emerging Technology Partners and ROMA99.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
ROMA99 is recognized as a trusted online gaming platform.
grosvenorfund.com
etpventures.com
Manufacturing and distributing medical equipment for healthcare specialists in India.
1991vitalbiosystems.comChennai, India
Premium access

Investor details for Aptus Pharmaceuticals

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Aptus Pharma Limited (Aptus Pharmaceuticals)

Aptus Pharma Limited is the primary company behind Aptus Pharmaceuticals. The board of Aptus Pharma Limited currently have 6 directors; the longest-serving is Tejash Maheshchandra Hathi, appointed in 2010. 10 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Tejash Maheshchandra Hathi
DIN 03151221
Managing Director12 Aug 201016 yrs 3 moAptus Pharma Limited
Chetan Shantilal Lalseta
DIN 02547012
Director17 Jan 20242 yrs 10 moAptus Pharma Limited
Riddhish Natwarlal Tanna
DIN 03231612
Director17 Jan 20242 yrs 10 moAptus Pharma Limited
Jyotiben Hasmukhbhai Chandarana
DIN 10607059
Director20 May 20242 yrs 6 moAptus Pharma Limited
Sejal Harit Palan
DIN 10893463
Director06 Feb 20251 yr 9 moAptus Pharma Limited
Vikas Rambhai Jobanputra
DIN 10921323
Director06 Feb 20251 yr 9 moAptus Pharma Limited

Financials of Aptus Pharmaceuticals

Figures of Aptus Pharma Limited, the primary company behind Aptus Pharmaceuticals, for FY 2026. Revenue was ₹46.70 Cr (+90% year on year). Net profit was ₹4.60 Cr (10% margin). EBITDA was ₹7.43 Cr (16% margin). Revenue has grown at a compounded annual rate of +50% over three years.

  • ₹46.70 CrRevenue · FY 2026 · +90% YoY
  • ₹4.60 CrNet profit · 10% margin
  • ₹7.43 CrEBITDA · 16% margin
  • ₹6.86 CrPaid-up capital
  • 28Employees (provident fund records)
  • +50%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Aptus Pharma Limited are on its company page.

Premium access

Detailed financial statements for Aptus Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Aptus Pharmaceuticals

2 dated milestones of Aptus Pharmaceuticals across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded Aptus Pharmaceuticals is founded.
  2. Funding First funding round of $6.2M.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Aptus Pharmaceuticals

Premium access

Complete news archive for Aptus Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aptus Pharmaceuticals

Aptus Pharmaceuticals was founded in 2010 and raised its 1st funding round 1 year after it was founded.

Aptus Pharmaceuticals is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.

Aptus Pharmaceuticals is a funded company, having raised a total of $6.2M across 1 funding round to date. The company's 1st funding round was a Series A of $6.2M, raised on May 2011.

Aptus Pharmaceuticals has 28 employees.

The primary company behind Aptus Pharmaceuticals, Aptus Pharma Limited, reported revenue of β‚Ή46.70 Cr for FY 2026, up 90% year on year.

Aptus Pharmaceuticals was founded in 2010 and is located in Gaithersburg, United States. Operations are centered in the pharmaceutical sector, where drug discovery and formulation activities are undertaken. Research efforts are directed toward therapeutic solutions, with manufacturing processes handled domestically. The company maintains a presence through its domain aptuspharma.com, serving the healthcare industry in the region.

Aptus Pharmaceuticals offers Pharmaceutical Products and Export Services.

Aptus Pharmaceuticals has 3 investors. Key investors include Vital Bio Systems, Emerging Technology Partners, and ROMA99.

Aptus Pharmaceuticals operates through Aptus Pharma Limited.

The legal entities of Aptus Pharmaceuticals currently have 9 directors, including Ghanshyam Vinubhai Pansuriya, Kapilbhai Hasmukhbhai Chandarana, Tejash Maheshchandra Hathi and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available